Literature DB >> 468845

Purification of a high molecular weight human terminal deoxynucleotidyl transferase.

M R Deibel, M S Coleman.   

Abstract

Terminal deoxynucleotidyltransferase has been purified from lymphoblasts of leukemic patients. The enzyme has a molecular weight of approximately 62,000 as determined by gel filtration and nondenaturing gel electrophoresis and is not dissociated into subunits by sodium dodecyl sulfate. In contrast, the terminal transferase enzyme from calf thymus has a molecular weight of 42,000 as determined by gel filtration, and is dissociated into 2 subunits of Mr 30,000 and 8,000 by sodium dodecyl sulfate. The enzyme has an isoelectric point of 8.2 and kinetic characteristics which are similar to those of calf thymus terminal transferase. The apparent Km for purine nucleotide polymerization at saturating initiator concentration with Mg2+ is 0.2 mM and with Mn2+ is 0.05 mM. Like calf terminal transferase, the reaction velocity is higher in the presence of Mg2+ than Mn2+. ATP inhibits the reaction catalyzed by terminal transferase isolated from human lymphoblasts due to mutual recognition of ATP and dATP by a common site on the enzyme. Preliminary experiments indicate that human terminal transferase may contain a small amount of carbohydrate. This report represents the first purification to near homogeneity of terminal transferase from a tissue source other than calf thymus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468845

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Terminal deoxynucleotidyltransferase. Alignment of alpha- and beta-subunits of the core enzyme along the primary translation product.

Authors:  C M Beach; S K Chan; T C Vanaman; M S Coleman
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

2.  Properties of a terminal deoxyribonucleotidyltransferase isolated from wheat germ.

Authors:  T Brodniewicz-Proba; J Buchowicz
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

3.  T-cell specific avian TdT: characterization of the cDNA and recombinant enzyme.

Authors:  B Yang; K N Gathy; M S Coleman
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

4.  Affinity purification and refined structural characterization of terminal deoxynucleotidyltransferase.

Authors:  S A Fuller; A Philips; M S Coleman
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

5.  High-level expression of murine terminal deoxynucleotidyl transferase in Escherichia coli grown at low temperature and overexpressing argU tRNA.

Authors:  J B Boulé; E Johnson; F Rougeon; C Papanicolaou
Journal:  Mol Biotechnol       Date:  1998-12       Impact factor: 2.695

6.  Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes.

Authors:  D A Wiginton; M S Coleman; J J Hutton
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

7.  Terminal deoxynucleotidyl transferase (TdT) and membrane receptors in human leukemia and lymphoma -- first experience with lyophilized cells.

Authors:  O Wetter; D K Hossfeld; K H Linder; D Brandhorst
Journal:  Klin Wochenschr       Date:  1981-04-15

8.  Biochemical and immunological properties of human terminal deoxynucleotidyl transferase purified from blasts of acute lymphoblastic and chronic myelogenous leukemia.

Authors:  M R Deibel; M S Coleman; K Acree; J J Hutton
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

9.  The two isoforms of mouse terminal deoxynucleotidyl transferase differ in both the ability to add N regions and subcellular localization.

Authors:  L A Bentolila; M Fanton d'Andon; Q T Nguyen; O Martinez; F Rougeon; N Doyen
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

10.  Terminal deoxynucleotidyl transferase in human lymphomas: possible existence of forms with high and low molecular weights.

Authors:  P Vezzoni; F Campagnari; G Di Fronzo; L Clerici
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.